Skip to content

Clinical trials

Phase 2 Neuralgia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Phase: Phase 2 Clear all

146 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20043
20053
20064
20079
20088
200912
20108
20116
20129
20138
20147
20153
20165
20175
20185
20197
20206
20215
20225
20232
20245
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79
Terminated32
Unknown status14
Withdrawn7
Recruiting6
Not yet recruiting4
Suspended2
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Clermont-Ferrand7
GlaxoSmithKline5
AstraZeneca4
NeurogesX4
Grünenthal GmbH3
National Institute of Dental and Craniofacial Research (NIDCR)3
Virginia Commonwealth University3
XenoPort, Inc.3
AbbVie (prior sponsor, Abbott)2
Aziende Chimiche Riunite Angelini Francesco S.p.A2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia146
Pain33
Neuralgia, Postherpetic21
Diabetic Neuropathies20
Peripheral Nervous System Diseases14
Chronic Pain13
Herpes Zoster13
Agnosia10
Diabetes Mellitus9
Hyperalgesia6

Trials

Showing 76 to 100 of 146. Each trial links to its page on Pharma Observatory.

46 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.